PTPRS and pneumococcal infection: Targeting the negative regulators, Dusp1 and Ptprs may prove not to be a viable treatment for aging individuals with pneumococcal infections as they are needed to restrain excessive inflammation, and instead, the focus should be on reducing the root cause of excessive inflammation.